Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Online Reports

 

Volume 32—2026

Volume 32, Number 3—March 2026

Cover of issue Volume 32, Number 3—March 2026

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group [PDF - 895 KB - 9 pages]
A. C. Pasqualotto et al.

Histoplasmosis remains a neglected yet deadly fungal infection, disproportionately affecting persons living with HIV/AIDS and other immunocompromised populations in endemic regions. Despite the World Health Organization’s designation of Histoplasma as a high-priority pathogen, the disease remains underdiagnosed and excluded from national surveillance systems, resulting in delayed treatment and high death rates. To coordinate a global response, the International Society for Human and Animal Mycology convened a Histoplasmosis Working Group during its 2025 congress in Brazil. Experts engaged in structured discussions across 5 domains: awareness, research, diagnostics and treatment, capacity building, and fungal biology. The group highlighted persistent diagnostic delays, underuse of antigen testing, and poor access to liposomal amphotericin B and itraconazole. Innovations such as lateral flow assays and molecular tools were discussed, alongside the need for biobanks and validated diagnostic algorithms. A global 90–90–90 target for histoplasmosis by 2030 was proposed to improve diagnosis, treatment, and survival.

EID Pasqualotto AC, Denning DW, Le T, Govender NP, Hagen F, Zancope-Oliveira RM, et al. New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerg Infect Dis. 2026;32(3):1-9. https://doi.org/10.3201/eid3203.251165
AMA Pasqualotto AC, Denning DW, Le T, et al. New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerging Infectious Diseases. 2026;32(3):1-9. doi:10.3201/eid3203.251165.
APA Pasqualotto, A. C., Denning, D. W., Le, T., Govender, N. P., Hagen, F., Zancope-Oliveira, R. M....Adenis, A. (2026). New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerging Infectious Diseases, 32(3), 1-9. https://doi.org/10.3201/eid3203.251165.

Volume 32, Number 1—January 2026

Cover of issue Volume 32, Number 1—January 2026

Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024 [PDF - 308 KB - 7 pages]
K. Halpin et al.

Diseases caused by henipaviruses, exemplified by Hendra virus and Nipah virus, pose a serious risk to public health because of their epidemic potential and high case-fatality rates and the paucity of medical countermeasures to mitigate them. In December 2024, a group of 150 scientists from 16 countries convened in Geelong, Victoria, Australia, to mark the 30th anniversary of the discovery of Hendra virus. The Hendra@30 conference built upon its predecessor conference held in 2019 in Singapore, Nipah@20, by expanding its program across broader disciplines and integrating sessions on human sociology and disease ecology into the main scientific discussions. We describe key highlights from Hendra@30 and reflect on 4 key elements that have advanced henipavirus research and medical countermeasures research and development. We propose that integrating bat ecology into henipavirus research blueprints will enable development of ecologic countermeasures that prevent spillover and will complement existing preparedness and response efforts with evidence-based prevention strategies.

EID Halpin K, Román R, de Wit E, Peel AJ, Epstein JH, Barr J, et al. Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024. Emerg Infect Dis. 2026;32(1):1-7. https://doi.org/10.3201/eid3201.250979
AMA Halpin K, Román R, de Wit E, et al. Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024. Emerging Infectious Diseases. 2026;32(1):1-7. doi:10.3201/eid3201.250979.
APA Halpin, K., Román, R., de Wit, E., Peel, A. J., Epstein, J. H., Barr, J....Markotter, W. (2026). Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024. Emerging Infectious Diseases, 32(1), 1-7. https://doi.org/10.3201/eid3201.250979.

 

Page created: December 18, 2025
Page updated: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external